Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, not recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

NCT04258137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Centre hospitalier de la Côte Basque Bayonne, France
  • Clinique Tivoli-Ducos Bordeaux, France
  • Institut Bergonie Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
View Trial Details
Active, not recruiting

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

NCT06012435

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center Fullerton, California, United States
  • Providence St. Jude Medical Center Fullerton, California, United States
View all 331 locations
View Trial Details
Active, not recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT05256290

Conditions
Advanced Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Huntington Beach Huntington Beach, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 25 locations
View Trial Details
Active, not recruiting

Plasma-Adapted First-Line Pembro In NSCLC

NCT04166487

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber at Steward St. Elizabeth's Medical Center Brighton, Massachusetts, United States
View Trial Details
Active, not recruiting

A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)

NCT05060016

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Christiana Care Health Services Newark, Delaware, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 80 locations
View Trial Details
Active, not recruiting

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

NCT03485209

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSD Koman Family Outpatient Pavilion La Jolla, California, United States
View all 175 locations
View Trial Details
Active, not recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT06447662

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +29 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 27 locations
View Trial Details

Related conditions